ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 294 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,688,000 | +525.2% | 41,752 | +789.7% | 0.02% | +433.3% |
| Q2 2015 | $270,000 | -65.3% | 4,693 | -61.5% | 0.00% | -62.5% |
| Q1 2015 | $777,000 | -25.9% | 12,200 | -28.2% | 0.01% | +14.3% |
| Q4 2014 | $1,049,000 | +86.3% | 17,000 | +17.2% | 0.01% | +133.3% |
| Q3 2014 | $563,000 | -61.6% | 14,500 | -66.0% | 0.00% | -57.1% |
| Q2 2014 | $1,468,000 | -39.8% | 42,600 | -24.5% | 0.01% | -50.0% |
| Q1 2014 | $2,439,000 | -37.0% | 56,455 | -41.9% | 0.01% | -33.3% |
| Q4 2013 | $3,869,000 | +37.1% | 97,129 | +29.2% | 0.02% | +16.7% |
| Q3 2013 | $2,821,000 | +41.3% | 75,151 | +1.2% | 0.02% | +50.0% |
| Q2 2013 | $1,996,000 | – | 74,287 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crosspoint Capital Strategies, LLC | 600 | $37,000 | 0.01% |
| PRENTISS SMITH & CO INC | 200 | $12,000 | 0.01% |
| MARSHALL & SULLIVAN INC /WA/ | 100 | $4,000 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |